A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Duke University
University Health Network, Toronto
Turning Point Therapeutics, Inc.
Milton S. Hershey Medical Center
Tempus AI
NantBioScience, Inc.
Comprehensive Support Project for Oncology Research